Burton Enright Welch’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$893K Sell
3,518
-219
-6% -$51K 0.1% 69
2026
Q1
$913K Sell
3,737
-326
-8% -$75.9K 0.12% 67
2025
Q4
$841K Buy
4,063
+195
+5% +$38.6K 0.12% 66
2025
Q3
$717K Buy
3,868
+5
+0.1% +$857 0.11% 72
2025
Q2
$590K Buy
3,863
+471
+14% +$72.4K 0.1% 73
2025
Q1
$563K Buy
3,392
+451
+15% +$70.6K 0.11% 62
2024
Q4
$425K Buy
2,941
+5
+0.2% +$775 0.09% 73
2024
Q3
$476K Hold
2,936
0.1% 64
2024
Q2
$429K Sell
2,936
-244
-8% -$36.3K 0.1% 66
2024
Q1
$503K Buy
3,180
+22
+0.7% +$3.5K 0.12% 60
2023
Q4
$495K Sell
3,158
-388
-11% -$59.5K 0.13% 57
2023
Q3
$552K Sell
3,546
-223
-6% -$36.8K 0.17% 44
2023
Q2
$624K Buy
3,769
+281
+8% +$45.4K 0.19% 40
2023
Q1
$541K Buy
3,488
+388
+13% +$62.7K 0.21% 41
2022
Q4
$548K Sell
3,100
-124
-4% -$21.4K 0.23% 37
2022
Q3
$527K Buy
+3,224
New +$546K 0.26% 39

Other funds holding JNJ

Burton Enright Welch's JNJ Position: Q2 2026 in Review

Burton Enright Welch reduced its Johnson & Johnson (JNJ) stake by 5.9% in Q2 2026, selling an estimated $51K and leaving 3,518 shares worth $893K. The position accounts for 0.1% of the portfolio, ranked #69.

Burton Enright Welch first reported a position in JNJ in Q3 2022 and has held it in 16 quarters since. The position peaked at $913K in Q1 2026. 4,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Burton Enright Welch held 3,518 shares of Johnson & Johnson worth $893K as of Q2 2026.
  • Burton Enright Welch sold 219 Johnson & Johnson shares in Q2 2026, an estimated $51K.
  • Johnson & Johnson made up 0.1% of Burton Enright Welch's portfolio in Q2 2026, its #69 holding.
  • Burton Enright Welch first reported a position in Johnson & Johnson in Q3 2022 and has held it in 16 quarters since.
  • Burton Enright Welch's Johnson & Johnson position peaked at $913K in Q1 2026.
  • 4,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Burton Enright Welch's 13F filing for Q2 2026, filed 17 Jul 2026.